FDA Clears Chewable Methylphenidate (QuilliChew) for ADHDFDA Clears Chewable Methylphenidate (QuilliChew) for ADHD

QuilliChew extended-release (Pfizer) is for treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older. FDA Approvals
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news